A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1.
published in: Journal of Hepatology
date of publication: 2013-02-22
main subject: ribavirin, chronic hepatitis C, chronic hepatitis
Cites articles
There is nothing here
Article - wd:Q42989590